secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2022-09-12T23:59:59+00:00
Accession:  0001193125-22-242861
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Frequency Therapeutics posts updated corporate slide presentation on website
----------------------------------------------------------------------------

- Updated slide deck posted to Investors & Media section of frequencytx.com on September 12, 2022.
- Presentation covers Frequency's regenerative medicine platform and pipeline strategy.
- No financial results, clinical data, or material operational updates were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312522242861/0001193125-22-242861-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312522242861/d572451d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-242861

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer